Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Treatment during development affects hormone balance and sexual behavior in male rats.

Higher fluoride levels may delay puberty in boys.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Most women with PCOS have insulin resistance, especially those with phenotype B.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Finasteride causes lasting fertility decrease in rats.

Hirsutism causes significant psychological distress in women.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.